CLINICAL_TRIALS
trial_result
· 2018-06-20
Clinical Trial Update: A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer [Phase 2]
Summary
Phase 2 clinical trial of LY2495655 in pancreatic cancer completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-06-20